Open Access
Volume 20, 2013
Article Number 37
Number of page(s) 6
Published online 21 October 2013
  1. Aubouy A, Bakary M, Keundjian A, Mbomat B, Makita JR, Migot-Nabias F, Cot M, Le Bras J, Deloron P. 2003. Combination of drug level measurement and parasite genotyping data for an improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacy in treating Plasmodium falciparum malaria in Gabonese children. Antimicrobial Agents and Chemotherapy, 47, 231–237. [CrossRef] [PubMed] [Google Scholar]
  2. Bogreau H. 2007. Diversité, multiplicité des infections et résistance aux antipaludiques de Plasmodium falciparum dans un essai contrôlé de moustiquaires imprégnées d’insecticide en zone de forte endémie. [Google Scholar]
  3. Bharti K, Shukla MM, Sharma YD, Singh N. 2012. Genetic diversity in the block 2 region of the merozoite surface protein-1 of Plasmodium falciparum in central India. Malaria Journal, 11, 78. [CrossRef] [PubMed] [Google Scholar]
  4. Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, Mellouk S, Langsley G. 1998. A primary malarial infection is composed of a very wide range of genetically diverse but elated parasites. Journal of Clinical Investigation, 101, 2008–2016. [CrossRef] [Google Scholar]
  5. Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F. 2002. Plasmodium falciparum merozoite surface protein 1 (msp-1): genotyping and humoral responses to allele-specific variants. Acta Tropica, 81, 33–46. [CrossRef] [PubMed] [Google Scholar]
  6. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1–2b trial in Papua New Guinea. Journal of Infectious Disease, 185, 820–827. [CrossRef] [Google Scholar]
  7. Guemouri SJ, Boudin C, Fievet N, Ndiaye P, Deloron P. 2006. Plasmodium falciparum genotype population dynamics in asymptomatic children from Senegal. Microbes and Infection, 8, 1663–1670. [CrossRef] [Google Scholar]
  8. Heidari A, Keshavarz H, Rokni MB, Jelinek T. 2007. Genetic diversity in merozoite surface protein msp-1 and msp-2 genes of Plasmodium falciparumin a major endemic region of Iran. Korean Journal of Parasitology, 45, 59–63. [CrossRef] [Google Scholar]
  9. Issifou S, Djikou S, Sanni A, Lekoulou F, Ntoumi F. 2001. Pas d’influence de la saison de transmission ni de l’âge des patients sur la complexité et la diversité génétique des infections dues à Plasmodium falciparum à Cotonou (Bénin). Bulletin de la Société de Pathologie Exotique, 94, 195–198. [Google Scholar]
  10. Khaminsou N, Kritpetcharat O, Daduang J, Charerntanyarak L, Kritpetcharat P. 2011. Genetic analysis of the merozoite surface protein-1 blocks 2 allelic types in Plasmodium falciparum clinical isolates from Lao PDR. Malaria Journal, 10, 371. [CrossRef] [PubMed] [Google Scholar]
  11. Koukouikila-Koussounda F, Malonga V, Mayengue PI, Ndounga M, Vouvoungui CJ, Ntoumi F. 2012. Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections. Malaria Journal, 11, 105. [CrossRef] [PubMed] [Google Scholar]
  12. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F. 2007. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the republic of Congo. Acta Tropica, 95, 219–225. [CrossRef] [Google Scholar]
  13. Mayengue PI, Luty AJ, Rogier C, Baragatti M, Kremsner PG, Ntoumi F. 2009. The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes and Infection, 11, 108–111. [CrossRef] [Google Scholar]
  14. Mayengue PI, Ndounga M, Malonga FV, Bitemo M, Ntoumi F. 2011. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo. Malaria Journal, 10, 276. [CrossRef] [PubMed] [Google Scholar]
  15. Mercereau-Puijalon O. 1996. Revisiting host/parasite interactions: molecular analysis of parasites collected during longitudinal and cross-sectional surveys in humans. Parasite Immunology, 18, 173–180. [CrossRef] [PubMed] [Google Scholar]
  16. Miller LH, Roberts T, Shahabuddin M, Mc Cutchan TF. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (msp-1). Molecular and Biochemical Parasitology, 59, 1–14. [CrossRef] [PubMed] [Google Scholar]
  17. Mwingira F, Nkwengulila G, Schoepflin S, Sumari D, Beck HP, Snounou G, Felger I, Olliaro P, Mugittu K. 2011. Plasmodium falciparum msp-1, msp-2 and glurp allele frequency and diversity in sub-Saharan Africa. Malaria Journal, 10, 79. [CrossRef] [PubMed] [Google Scholar]
  18. Ojurongbe O, Fagbenro-Beyioku AF, Adeyeba OA, Kun JF. 2011. Allelic diversity of merozoite surface protein 2 gene of P. falciparum among children in Osogbo, Nigeria. West Indian Medical journal, 60, 19–23. [Google Scholar]
  19. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene, 52, 565–568. [Google Scholar]
  20. Programme national de lutte contre le paludisme. Plan stratégique de lutte contre le paludisme au Bénin 2006-2010. [Google Scholar]
  21. Schoepflin S, Valsangiacomo F, Lin E, Kiniboro B, Mueller I, Felger I. 2009. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malaria Journal, 8, 250. [CrossRef] [PubMed] [Google Scholar]
  22. Singh N, Shukla MM, Chand G, Bharti PK, Singh MP, Shukla MK, Mehra RK, Sharma RK, Dash AP. 2011. Epidemic of Plasmodium falciparum malaria in Central India, an area where chloroquine has been replaced by artemisinin-based combination therapy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 105, 133–139. [CrossRef] [PubMed] [Google Scholar]
  23. Smythe JA, Peterson MG, Coppel RL, Saul AJ, Kemp DJ, Anders RF. 1990. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Molecular and Biochemical Parasitology, 39, 227–234. [CrossRef] [PubMed] [Google Scholar]
  24. Snewin VA, Herrera M, Sanchez G, Scherf A, Langsley G, Herrera S. 1991. Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia. Molecular and Biochemical Parasitology, 49(2), 265–275. [CrossRef] [PubMed] [Google Scholar]
  25. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 369–377. [CrossRef] [PubMed] [Google Scholar]
  26. Soulama I, Nebie I, Ouedraogo A, Gansane A, Diarra A, Tiono AB, Bougouma EC, Konate AT, Kabre GB, Taylor WRJ, Sirima SB. 2009. Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso. Malaria Journal, 8, 135. [CrossRef] [PubMed] [Google Scholar]
  27. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. 2008. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malaria Journal, 7, 17. [CrossRef] [PubMed] [Google Scholar]
  28. WHO. 2000. Communicable diseases cluster: severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 0S1–S9. [Google Scholar]
  29. Yuan L, Zhao H, Wu L, Li X, Parker D, Xu S, Zhao Y, Feng G, Wang Y, Yan G, Fan Q, Yang Z, Cui L. 2013. Plasmodium falciparum populations from northeastern Myanmar display high levels of genetic diversity at multiple antigenic loci. Acta Tropica, 125, 53–59. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.